Richard M Evans

Title: Richard M Evans: Innovator in Pharmaceutical Formulations

Introduction

Richard M Evans is a notable inventor based in Cary, NC (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative formulations. His work focuses on improving the stability and efficacy of pharmaceutical compounds.

Latest Patents

Richard M Evans holds a patent for "Pharmaceutical latrunculin formulations." This invention relates to an aqueous pharmaceutical formulation that comprises at least one latrunculin without a substantial amount of dimethyl sulfoxide. The formulation includes latrunculin in an amount of 0.001-2% w/v, a non-ionic surfactant in an amount of 0.01-2% w/v, and a tonicity agent to maintain a tonicity between 200-400 mOsm/kG, at a pH between 4 to 8. The formulation is designed to be stable for at least six months at refrigerated temperatures. It also provides methods for reducing intraocular pressure, treating glaucoma, inhibiting wound healing after trabeculectomy, and inhibiting angiogenesis.

Career Highlights

Richard M Evans is associated with Inspire Pharmaceuticals, Inc., where he has contributed to various innovative projects. His expertise in pharmaceutical formulations has been instrumental in advancing the company's research and development efforts.

Collaborations

He has collaborated with notable colleagues such as Ramesh Krishnamoorthy and Leo A Trevino, enhancing the collective knowledge and innovation within the team.

Conclusion

Richard M Evans exemplifies the spirit of innovation in the pharmaceutical industry through his groundbreaking work on latrunculin formulations. His contributions continue to impact the field positively.